Peak Bio, Inc.

Peak Bio, Inc., filing under ticker IGNY, submitted an 8-K to the Securities and Exchange Commission on November 14, 2024. IGNY is the trading symbol associated with Ignyte Acquisition Corp, a blank-check company sponsored by Ignyte Sponsor LLC that completed a de-SPAC business combination with Peak Bio, a clinical-stage biopharmaceutical company developing therapies for hematological disorders and oncology indications. Ignyte Acquisition Corp conducted its initial public offering in 2021, targeting the healthcare and life sciences sector. The November 2024 current report reflects continuing SEC disclosure obligations for the post-merger combined entity. For full filing history, sponsor profiles, and deal analytics on IGNY, sign up for complete data access at SpacDesk.